SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-063618
Filing Date
2024-03-08
Accepted
2024-03-08 16:01:02
Documents
15
Period of Report
2024-03-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d797682d8k.htm   iXBRL 8-K 27219
2 EX-99.1 d797682dex991.htm EX-99.1 183028
  Complete submission text file 0001193125-24-063618.txt   383800

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA eq-20240306.xsd EX-101.SCH 2846
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE eq-20240306_lab.xml EX-101.LAB 18756
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eq-20240306_pre.xml EX-101.PRE 11709
17 EXTRACTED XBRL INSTANCE DOCUMENT d797682d8k_htm.xml XML 3795
Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037 (858) 412-5302
Equillium, Inc. (Filer) CIK: 0001746466 (see all company filings)

IRS No.: 821554746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38692 | Film No.: 24734195
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)